Journal article
Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes
- Publication status:
- Published
Actions
Authors
- Journal:
- DIABETOLOGIA More from this journal
- Volume:
- 55
- Pages:
- S314-S315
- Publication date:
- 2012-10-01
- ISSN:
-
0012-186X
- Pubs id:
-
pubs:448682
- UUID:
-
uuid:013d460a-c7fc-4173-9310-aa8d15b37ab6
- Local pid:
-
pubs:448682
- Source identifiers:
-
448682
- Deposit date:
-
2014-10-07
- ARK identifier:
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record